UNSPSC 51281509: Terizidone

This classification denotes an antitubercular agent with the molecular formula C14H14N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1199LEX5N8, chemically known as 4,4-(p-phenylenebis(methyleneamino))di-(isoxazolidin-3-one) but generally known as terizidone, which bears US NIH Compound Identifier 65720. European Medicines Agency schedules Terizidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15487MIG. The term TERIZIDONE is an International Non-Proprietary Name.

UNSPSC 51281509 Terizidone is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local opportunities posted under this code do not reflect terizidone procurement. Instead, the opportunities solicited antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), opioid antagonists (Naloxone), and drug deactivation systems. State and local health departments and county public health offices use codes in this pharmaceutical family to procure both routine medications and emergency-response pharmaceutical supplies, typically through piggyback arrangements with multi-agency cooperative purchasing vehicles, competitive sealed bids, and term contracts with renewal options. The issuing bodies in recent activity include state departments of public health and county health and community services offices.

Recent opportunities span Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical supply contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 via Invitation for Bid 26482DPHPREPDB53392, covering a 12-month initial term with two renewal options for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets. Seminole County, Florida released an Invitation for Bid (IFB 60459723LAS) on June 30, 2026, with a response deadline of July 26, 2026, to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually on a two-year contract with a one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Neither opportunity directly addresses terizidone procurement, indicating that the code shows little relevant recent activity for the pharmaceutical compound it nominally covers.